<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1610246063
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1982
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MYDFRIN 2.5% DROPS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PHENYLEPHRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALCON LABORATORIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALCON LABORATORIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 392]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL-KAMAL IMPORT OFFICE CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ALCON LABORATORIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01FB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        S01GA05
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Phenylephrine hydrochloride is a sympathomimetic agent that acts directly on &alpha;-adrenergic blocking receptors. Topical application causes pupillary dilation and blanching of the conjunctiva.<br />MYDFRIN eye drops, solution is used for constricting the blood vessels, for increasing the pupil size and as a decongestant in a variety of ophthalmic conditions and diagnostic procedures. It is also used for many ophthalmic surgical procedures.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use MYDFRIN* Eye Drops</strong><br />&bull; If you are allergic (hypersensitive) to MYDFRIN or any of the other ingredients of<br />MYDFRIN Eye Drops<br />&bull; If you have narrow angle glaucoma.<br />&bull; In newborns and infants with cardiovascular or cerebrovascular problems and in some elderly adults with severe thickening of blood vessels, cardiovascular or cerebrovascular problems.</p><p><br /><strong>Warnings and precautions</strong><br />&bull; Use with caution in children, the elderly, patients with insulin dependent diabetes<br />or high blood pressure, or those who experience a decrease in blood pressure related to postural change, or in patients with overactive thyroid.<br />&bull; If you are being treated with monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, antihypertensive agents, or atropine.<br />&bull; Wash hands after handing the bottle or after instillation of the product.<br />&bull; If you are taking other medicines, please, also read the section &ldquo;Using other medicines&rdquo;.</p><p><br /><strong>Children</strong><br />&bull; Do not use in preterm and newborn infants unless clearly necessary and recommended by the doctor. Low birth weight and premature infants may be at an increased risk for side effects including temporary increases in blood pressure. The infant should be monitored after instillation. Please seek emergency service in case of serious side effects<br />&bull; The lowest dose necessary to produce the desired effect should always be used.<br />Instillation of more than one drop per eye must be avoided.<br />&bull; Do not get MYDFRIN Eye Drops in your child&rsquo;s mouth or cheeks; wash your hands and your child&rsquo;s hands or cheeks immediately after administration.</p><p><br /><strong>Other medicines and MYDFRIN* Eye Drops</strong><br />Please tell your doctor or pharmacist if you are taking or have recently taken any<br />other medicines, including medicines obtained without a prescription.</p><p><br />Especially tell your doctor if you are taking or may be exposed to:<br />&bull; monoamine oxidase inhibitors (MAOIs).<br />&bull; tricyclic antidepressants and antihypertensive agents (guanethidine, reserpine, and non- selective beta blockers such as propanolol)<br />&bull; atropine<br />&bull; inhalation anesthetic agents</p><p><br />Tell your doctor or pharmacist if you are using, have recently used or might use any<br />other medicines.</p><p><br /><strong>Pregnancy and breast-feeding</strong><br />Ask your doctor for advice before taking any medicine.<br />MYDFRIN Eye Drops should not be used during pregnancy or breast-feeding.<br />If you are pregnant or breast-feeding, you think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p><br /><strong>Driving and using machines</strong><br />You may find your vision is blurred for a time after you use MYDFRIN Eye Drops. Do not drive or use machines until this has worn off.</p><p><br /><strong>MYDFRIN* Eye Drops contains benzalkonium chloride</strong><br />A preservative in MYDFRIN Eye Drops (benzalkonium chloride) may cause eye irritation and is also known to discolour soft contact lenses. If you wear contact lenses, you should remove them before using MYDFRIN Eye Drops and wait at least 15 minutes before putting your lenses back in.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor or pharmacist or nurse has told you. Check with your doctor or pharmacist or nurse if you are not sure.<br /><br />Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist or nurse has told you. Check with your doctor or pharmacist or nurse if you are not sure.<br />- Only use MYDFRIN Eye Drops for dropping in your eye(s)<br />- After cap is removed, if tamper evident snap collar is loose, remove before using product.<br />- The following measure is useful to limit the amount of medicine that will come into the blood after application of eye drops:<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; o Keep the eyelid closed, while simultaneously applying gentle pressure to the lachrymal canal with a finger.</p><p><br /><strong>If a drop misses your eye</strong>, try again.<br /><strong>If you use more MYDFRIN Eye Drops than you should, </strong>rinse it all out with warm<br />water. Do not put in any more drops until it is time for your next regular dose.</p><p><br /><strong>If you forget to use MYDFRIN Eye Drops</strong> continue with the next dose as planned.<br />However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use a double dose to make up.</p><p><br /><strong>If you have any further questions on the use of this medicine, ask your doctor<br />or pharmacist or nurse.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects have been seen with MYDFRIN Eye Drops. Frequency cannot be estimated from the available data:<br />Not known (frequency cannot be estimated from the available data):<br />- Effects in the eye: eye pain, eye irritation, eye redness, inflammation of the conjunctiva<br />- General side effects: allergy (hypersensitivity), dizziness, increased heart rate, fluid in the lungs, skin inflammation, increased blood pressure.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C.<br />Protect from light and excessive heat.<br />Do not use this medicine after the expiry date which is stated on the packaging.<br />Discard 4 weeks after first opening.<br />Keep this medicine out of the sight and reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Active ingredients: 25 mg of phenylephrine hydrochloride in one mL solution (2.5%)<br />Preservative: benzalkonium chloride</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                2.5% in 5ml plastic DROPTAINER™ dispenser.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Alcon Research Limited,<br />Fort Worth,<br />Texas 76134,<br />USA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>فينيل إيفرين هيدروكلوريد&nbsp;هو محاكي للودي السمبثاوي يؤثر&nbsp;بشكل مباشر على مستقبلات ألفا الأدرينية. يُسبب الاستعمال الموضعي اتساع الحدقة وابيضاضاً في الملتحمة.<br /><strong>يستخدم عقار ميدفرين قطرات للعين، محلول،</strong> لتضييق الأوعية الدموية، ولزيادة حجم حدقة العين وكمزيل للاحتقان في&nbsp;مجموعة متنوعة من حالات العين والإجراءات التشخيصية. يستخدم&nbsp;أيضاً&nbsp;في العديد من العمليا الجراحية بالعين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم عقار ميدفرين قطرات للعين في الحالات الآتية:</strong><br />&bull; إذا كنت تعاني من الحساسية &quot;فرط الحساسية&quot; تجاه عقار ميدفرين أو أي من مكوناته.<br />&bull; إذا كنت مصاباً بمياه زرقاء ضيقة الزاوية.<br />&bull; في الأطفال حديثي الولادةوالرضع ممن لديهم مشاكل بالأوعية الدموية للقلب أو للمخ وفي بعض المرضى من كبار السن ممن لديهم ازدياد شديد في سمك الأوعية الدموية، أو مشاكل بالأوعية الدموية للقلب أو المخ.</p><p><br /><strong>تحذيرات واحتياطات</strong><br />&bull;&nbsp;يستخدم&nbsp;بحذر في المرضى من الأطفال، وكبار السن، والمرضى ممن يعانون من السُّكَّرِي المعتمد على الأنسولين&nbsp;أو ارتفاع ضغط الدمَّ، أو هؤلاء الذين يعانون من انخفاض ضغط الدمَّ المرتبط بالتغير&nbsp;الوضعي أو المرضى الذين يعانون من فرط نشاط الغدة الدرقية.<br />&bull; إذا كان یتم علاجك بمثبطات أكسيداز أحادي الأمين، أو مضادات الاكتئاب ثلاثية الحلقات، أو الأدوية الخافضة لضغط الدم،&nbsp;أو الأتروبين.<br />&bull; اغسل يديك بعد التعامل مع الزجاجة أو بعد التقطير من المنتج.<br />&bull; إذا كنت تتناول أدوية أخرى، يرجى أيضاً قراءة القسم: &quot;استخدام أدوية أخرى&quot;.</p><p><br /><strong>الأطفال</strong><br />&bull; لا يستخدم في الأطفال المبتسترين والرُّضع حديثي الولادة ما لم تكن هناك ضرورة ملحة وما لم يوصي الطبيب&nbsp;بذلك. قد يزيد خطر انخفاض وزن المواليد والأطفال المبتسرين&nbsp;من الآثار الجانبية بما في ذلك ارتفاعات مؤقتة في&nbsp;ضغط الدمَّ. یجب مراقبة الرَّضيع بعد التقطير. يرجى طلب خدمة الطوارئ في حالة الإصابة بأعراض جانبية خطيرة.<br />&bull; يجب&nbsp;دائمًا استخدام أقل جرعة ممكنة لتحقيق التأثير المرغوب.<br />&bull; يجب&nbsp;تجنب التقطير&nbsp;لأكثر من قطرة واحدة لكل عين.<br />&bull; لا تضع عقار ميدفرين قطرات للعين في فم طفلك أو على وجنته، اغسل يديك ويدي طفلك أو وجنته فوراً بعد الاستخدام.</p><p><br /><strong>الأدوية الأخرى وعقار ميدفرين قطرات للعین</strong><br />يرُجى إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أية أدوية أخرى، بما في ذلك الأدوية التي يتم&nbsp;الحصول عليها دون وصفة طبية.<br /><br />أخبر طبيبك خاصة إذا كنت تتناول أو قد تتعرض للآتي:<br />&bull; مثبطات أوكسيديز&nbsp;أحادي الأمين:<br />&nbsp;&bull; مضادات الاكتئاب ثلاثية الحلقات والأدوية الحافضة لضغط الدم (جوانيثيدين، ريسربين، وحاصرات بيتا غير الانتقائية مثا: بروبرانالول)<br />&bull; أتروبين<br />&bull; أدوية التخَّدير المُستنشَقة.<br />يرُجى إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تستخدم أو استخدمت مؤخرًا أو قد تستخدم أيةَّ أدوية&nbsp;أخرى.</p><p><br /><strong>الحمل والرضاعة الطبيعية</strong><br />استشيري طبيبك أو الصيدلي قبل تناول أي دواء.<br />يجب ألا يتم استخدام عقار ميدفرين قطرات للعين أثناء الحمل أو الرضاعة الطبيعية.<br />&nbsp;إذا كنت حاملاً أو مرضعاً، أو تعتقدين أنك حاملا أو تخططين لذلك، فاستشيري طبيبك أو الصيدلي الخاص بك قبل استخدام الدواء.</p><p><strong>القيادة واستخدام الآلات</strong><br />قد تجد أن لديك عدم وضوح بالرؤية لبعض الوقت بعد استخدام عقار ميدفرين قطرات للعين، لا تمارس القيادة أو استخدام الآلات حتى يزول هذا التأَّثير.</p><p><br /><strong>يحتوي عقار ميدفرين* قطرات للعين على كلوريد البنزالكونيوم</strong><br />قد تسبب إحدى المواد الحافظة في عقار ميددفرين قطرات للعين (كلوريد البنزالكونيوم) تهيجً بالعين، ومن المعروف أنها تسبب تغير في&nbsp;تغيير لون العدسات اللاصقة اللينة. إذا كنت ترتدي عدسات لاصقة، فيجب عليك نزعها قبل استخدام عقار ميدفرين قطرات للعين وانتظر على الأقل لمدة 15 دقيقة قبل إعادة ارتدائها..</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>أستخدم دائمًا هذ الدوَّاء كما أخبرك الطبيب أو الصيدلي أو الممرض(ة) الخاص بك بالضبط يرجى مراجعة الطبيب أو الصيدلي أو الممرض(ة) الخاص بك إذا لم تكن متأكداً من كيفية&nbsp;الاستخدام.</p><p><br />أستخدم دائمًا هذا&nbsp;الدوَّاء كما هو&nbsp;موصوف في هذه النشرة أو كما أخبرك الطبيب أو الصيدلي أو الممرض(ة) الخاص بك إذا لم تكن متأكداً من كيفية الاستخدام.</p><p><br />&bull; استخدم عقار ميدفرين قطرات لعين للتقطير في عينيك فقط.<br />&bull; بعد نزع الغطاء، إذا كان عنق غطاء العبوة غير محكم، قم بإزالته قبل استخدام المنتج.<br />&bull; يعد الإجراء التاَّلي مفدياً للحد من كمية الدوَّاء التي تمر في الدمَّ بعد وضع قطرات العین:<br />&bull; إبقاء الجفن مغلقًا، بصورة متزامنة أثناء وضع القطرة مع الضَّغط الخفيف&nbsp;على القناة الدمعية بإصبعك.</p><p><br /><strong>إذا لم تدخل إحدى القطرات في عينيك</strong>، فكرر المحاولة.</p><p><br /><strong>إذا استخدمت كمية أكثر مما يجب من عقار ميدفرين* قطرات للعين</strong>، فاشطف عينيك بالكامل بالماء الداَّفئ. لا تضع المزيد من القطرات حتى يحين موعد جرعتك المعتادة التالية.<br /><strong>إذا أغفلت استخدام عقار ميدفرين قطرات للعين</strong> فاستمر في استخدامه بتلقي الجرعة التالية حسب الموعد المحدد. ومع ذلك، إذا كان هذا الوقت هو وقت الجرعة التالية تقريباً،&nbsp;فاترك الجرعة التي أغفلتها وعد لاستئناف جدول جرعاتك المعتاد. لا تستخدم جرعة مضاعفة لتعويض الجرعة التي نسيتها.</p><p><br /><strong>إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدَّواء، فاستشر الطبيب أو الصيدلي أو الممرض(ة) الخاص بك.</strong><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كافة الأدوية، قد يسُبب هذا الدوَّاء آثارًا جانبية، على الرَّغم من عدم حدوثها لدى الجميع. شوهدت الآثار الجانبية التاَّلية<br />عند استخدام عقار ميدفرين قطرات للعين: لا يمكن تقدير معدلات التكرار من واقع البيانات المتاحة:<br />غير معروفة: (لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة):<br />&bull; الآثار الجانبية بالعين: ألم بالعين، تهيج العين، احمرار بالعين، التهاب الملتحمة.<br />&bull;&nbsp; الآثار الجانبية العامة: حساسية (فرط الحساية)،&nbsp;الدوخة، ارتفاع معدل ضربات القلب، وجود سائل بالرئتين، التهاب الجلد، ارتفاع ضغط الدم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفَظ في درجة حرارة أقل من 30 درجة مئوية.<br />يحفظ الدواء بعيدا من الضوء و درجة الحرارة العالية<br />لا تَستخدِم هذا الدَّواء بعد تاريخ انتهاء الصلاحية المُدوَّن على العبوة.<br />قم بالتَّخلص من هذا الدوَّاء بعد أربعة أسابيع من فتحه لأول مرة.<br />يحفظ هذا الدَّواء بعيداً عن رؤية ومُتناوَل الأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المواد الفعالة: 25 مجم من فينيل إيفرين هيدروكلوريد في واحد مللي لتر محلو (2.5%) المادة الحافظة: كلوريد البنزالكونيوم</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>٪2.5 في قطرة بلاستيكية معقمة تحتوي على 5 مللي لتر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مختبرات شركة ألكون المحدودة،<br />فورت وورث، تكساس 76134<br />الولايات المتحدة الأمريكية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MYDFRIN* (25 mg/ml) Eye drops, Solution
Phenylephrine Hydrochloride
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredients: 25 mg of phenylephrine hydrochloride in one mL solution (2.5%)
Preservative: benzalkonium chloride
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye Drops, solution
Colorless to light yellow solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>MYDFRIN</strong> eye drops, solution is indicated<br />&bull; As a vasoconstrictor, decongestant, and mydriatic in a variety of ophthalmic conditions and procedures.<br />&bull; For pupillary dilation in uveitis (to prevent or aid in the disruption of posterior synechia formation).<br />&bull; For many ophthalmic surgical procedures<br />&bull; For refraction without cycloplegia.<br />&bull; For funduscopy and other diagnostic procedures.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><br /><u>Vasoconstriction and Pupil Dilation:</u><br />&bull; A drop of a suitable topical anesthetic may be applied, followed in a few minutes by 1 drop of MYDFRIN 25 mg/ml eye drops, solution on the upper limbus.<br />&bull; Repeat the instillation as necessary after 1 hour, preceded by the use of the topical anesthetic.</p><p><br /><u>Uveitis:</u><br />&bull; For recently formed posterior synechiae, 1 drop of MYDFRIN 25 mg/ml eye drops, solution may be applied to the upper surface of the cornea and repeated as necessary, not to exceed 3 times.<br />&bull; Treatment may be continued the following day, if necessary, not to exceed 3 times.</p><p><br /><u>Glaucoma:</u><br />&bull; MYDFRIN 25 mg/ml eye drops, solution may be used with miotics in patients with open angle glaucoma to reduce the difficulties experienced because of the small field produced by miosis, and still permit and support the effect of the miotic in lowering the intraocular pressure in open angle glaucoma. Marked improvement in visual acuity may occur after using MYDFRIN 25 mg/ml eye drops, solution in conjunction with miotic drugs.</p><p><br /><u>Surgery:</u><br />&bull; When a short-acting mydriatic is needed for wide dilation of the pupil before intraocular surgery, MYDFRIN 25 mg/ml eye drops, solution may be applied topically 30to 60 minutes before the operation.</p><p><br /><u>Refraction:</u><br />&bull; MYDFRIN 25 mg/ml eye drops, solution may be used effectively to increase mydriasis with homatropine hydrobromide, cyclopentolate hydrochloride, tropicamide hydrochloride and atropine sulfate.</p><p><br />FOR ADULTS<br />&bull; One drop of the preferred cycloplegic is placed in each eye, followed in 5 minutes by one drop of MYDFRIN 25 mg/ml eye drops, solution. Since adequate cycloplegia is achieved at different time intervals after the instillation of the necessary number of drops, different cycloplegics will require different waiting periods to achieve adequate cycloplegia.</p><p><br /><em>Paediatric population</em><br />&bull; For a &ldquo;one application method&rdquo;: MYDFRIN 25 mg/ml eye drops, solution may be combined with one of the preferred rapid acting cycloplegics to produce adequate cycloplegia.<br />&bull; For ophthalmoscopic Examination: One drop of MYDFRIN 25 mg/ml eye drops, solution is placed in each eye. Sufficient mydriasis to permit examination is produced in 15 to 30 minutes.<br />Dilation lasts from one to three hours.<br />&bull; For diagnostic Procedures: Provocative Test for Angle Closure Glaucoma: MYDFRIN25 mg/ml eye drops, solution may be used cautiously as a provocative test when interval narrow angle closure glaucoma is suspected. Intraocular tension and gonioscopy are performed prior to<br />and after dilation of the pupil with MYDFRIN HCl. A &ldquo;significant&rdquo; intraocular pressure (IOP) rise combined with gonioscopic evidence of angle closure indicates an anterior segment anatomy capable of angle closure. A negative test does not rule this out. This pharmacologically induced angle closure glaucoma may not simulate real life conditions and other causes for transient elevations of IOP should be excluded.</p><p><br />&bull; Retinoscopy (Shadow Test): When dilation of the pupil without cycloplegic action is desired for retinoscopy, MYDFRIN 25 mg/ml eye drops, solution may be used.</p><p><br />NOTE: Heavily pigmented irides may require larger doses in all of the above<br />procedures.</p><p><br />&bull; Blanching Test: One or two drops of MYDFRIN 25 mg/ml eye drops, solution should be applied to the injected eye. After five minutes, examine for perilimbal blanching. If blanching occurs, the congestion is superficial and probably does not indicate iridocyclitis.</p><p><br /><em>Geriatric population</em><br />&bull; No overall differences in safety or effectiveness have been observed between elderly and younger patients</p><p><br /><strong>Method of administration</strong><br />&bull; For ocular use only.<br />&bull; To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip. Keep the bottle tightly closed when not in use.<br />&bull; If you are using other eye drop or eye ointment medicines, leave at least 5 minutes between each medicine. Eye ointments should be administered last.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or to any of the excipients.
• MYDFRIN 25 mg/ml eye drops, solution are contraindicated in patients with anatomically narrow angles or narrow angle glaucoma.
• MYDFRIN 25 mg/ml eye drops, solution are contraindicated in newborns and infants with cardiovascular or cerebrovascular disease and in some elderly adults with severe arteriosclerotic, cardiovascular or cerebrovascular disease.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; Nasolacrimal occlusion or gently closing the eyelid after administration is recommended.<br />&bull; This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.<br />&bull; The use in preterm and newborn infants is not recommended unless clearly necessary.<br />&bull; The lowest possible dose should be used. Instillation of more than one drop per eye must be avoided (see section 4.4).<br />&bull; MYDFRIN 25 mg/ml eye drops, solution Use with caution in children and elderly or in patients with sympathetic denervation (e.g. patients with insulin dependent diabetes, orthostatic hypotension, hypertension, hyperthyroidism).<br />&bull; Use with caution, if at all, in patients taking monoamine oxidase inhibitors, tricyclic antidepressants, certain antihypertensive agents, or atropine. (See Section 4.5)<br />&bull; Systemic absorption may be enhanced when applying MYDFRIN Eye Drops to an instrumented, traumatised, diseased or postsurgical eye or adnexa, or to patients with suppressed lacrimation, as during anesthesia.<br />&bull; Rebound miosis has been reported in older persons one day after receiving MYDFRIN eye drops, and reinstillation of the drug may produce a reduction in mydriasis. This may be of clinical importance in dilating the pupils of older subjects prior to retinal detachment or cataract<br />surgery.<br />&bull; Due to a strong action of the drug on the dilator muscle, the use of MYDFRIN in the eye may liberate pigment granules from the iris, especially when given in high doses to elderly patients.<br />Paediatric population<br />&bull; Full-term, but especially low birth weight and premature infants may be at an increased risk for systemic adverse reactions including transient increases in blood pressure. The infant should be monitored after instillation and routines to adequately deal with emergency<br />situations should be in place.<br />&bull; The lowest dose necessary to produce the desired effect should always be used.<br />&bull; Parents should be warned not to get this preparation in their children&#39;s mouth or cheeks and to wash their hands and the child&#39;s hands or cheeks following administration.<br />&bull; MYDFRIN 25 mg/ml Eye Drops, Solution contain benzalkonium chloride which may cause eye irritation and is known to discolour soft contact lenses. Avoid contact with soft contact lenses. Patients must be instructed to remove contact lenses prior to application of MYDFRIN Eye Drops, Solution and wait at least 15 minutes before reinsertion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull; When administered simultaneously with, or up to 21 days after, administration of monoamine xidase (MAO) inhibitors, careful supervision and adjustment of dosages are required since exaggerated adrenergic effects may result. (See Section 4.4).<br />&bull; Use with caution, if at all, in patients taking tricyclic antidepressants and certain antihypertensive agents (guanethidine, reserpine, and non-selective beta blockers such as propanolol) as the pressor response is potentiated. (See Section 4.4).<br />&bull; Concomitant use of phenylephrine and atropine may enhance the pressor effects and induce tachycardia in some patients, especially infants. (See Section 4.4)<br />&bull; MYDFRIN may potentiate the cardiovascular depressant effects of potent inhalation anesthetic agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Fertility</u><br />&bull; Studies have not been performed to evaluate the effect of ocular administration of MYDFRIN Eye Drops on fertility.</p><p><br /><u>Pregnancy</u><br />&bull; There are no or limited amount of data from the use of MYDFRIN Eye Drops in pregnant women. However the available data with systemic use of MYDFRIN suggest some risk during pregnancy.</p><p><br /><u>Breast-feeding</u><br />&bull; It is not known whether MYDFRIN /metabolites are excreted into human milk after ocular administration. A risk to the suckling child cannot be excluded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs after instillation, the patient must wait until the vision clears before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been identified from post-marketing surveillance following administration of MYDFRIN Eye Drops, Solution. Frequency cannot beestimated from the available data.</p><table border="1" cellspacing="1" cellpadding="1" style="width:440.729px"><tbody><tr><td style="width:214px"><strong>System Organ Classification</strong></td><td style="width:225px"><strong>Adverse Reactions</strong></td></tr><tr><td style="width:214px">Immune system disorders</td><td style="width:225px">hypersensitivity</td></tr><tr><td style="width:214px">Nervous system disorders</td><td style="width:225px">dizziness</td></tr><tr><td style="width:214px">Eye disorders</td><td style="width:225px">eye pain, eye irritation, ocular hyperaemia, conjunctivitis</td></tr><tr><td style="width:214px">Cardiac disorders</td><td style="width:225px">blood pressure increased, tachycardia</td></tr><tr><td style="width:214px">Respiratory, thoracic and mediastinal disorders</td><td style="width:225px">pulmonary oedema</td></tr><tr><td style="width:214px">Skin and subcutaneous tissue disorders</td><td style="width:225px">dermatitis contact</td></tr></tbody></table><p><u>Description of selected adverse reactions</u><br />Systemic toxicity can result from topical application of sympathicomimetic drugs: headache, blood pressure elevation, extrasystoles, tachycardia, faintness and cerebrovascular accidents have been reported<br /><strong><em>--To reports any side effect(s):<br />&nbsp; &nbsp; &nbsp; &bull; Saudi Arabia:</em></strong><br />--The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&nbsp; &nbsp; &nbsp;<strong><em> &bull; Other GCC States:</em></strong><br />-- Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In case of accidental ingestion, MYDFRIN may cause hypertension, headache, seizures, cerebral haemorrhage, palpitation, paresthesia, or vomiting. Pulmonary oedema or cardiac arrest may occur.<br />MYDFRIN has a rapid onset and short duration of action, thus treatment of toxicity is supportive. The use of beta blockers and calcium channel blockers for the treatment of acute hypertension secondary to vasoconstriction should be avoided.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Sympathomimetics excl. antiglaucoma preparations ATC code: S01FB01</p><p><br /><strong>Mechanism of action</strong><br />Phenylephrine hydrochloride is a sympathomimetic agent that acts directly on &alpha;-adrenergic blocking receptors. Following topical application, MYDFRIN contracts the iris dilator muscle and smooth muscle of the conjunctival arterioles, causing pupillary dilation and blanching of the conjunctiva, respectively. Mueller&rsquo;s muscle of the upper lid is stimulated, which widens the palpebral fissure.</p><p><br /><strong>Pharmacodynamic effects</strong><br />Pharmacodynamic effects of PhE involve a 1-adrenergic stimulation: The subsequent hypertension is due to the increase in peripheral vascular resistances and increased filling pressures of the left ventricle. Afterload impedance on left ventricular ejection, and telediastolic volume and pressures, may in turn cause intense tachycardia or reflex bradycardia.</p><p><br /><strong>Clinical efficacy and safety</strong><br />Pupillary dilation following topical administration of phenylephrine hydrochloride ophthalmic solution has been demonstrated in controlled clinical studies in adults and pediatric patients with different levels of iris pigmentation. Pupil movement is generally seen within 15 minutes, maximal mydriasis between 20 to 90 minutes and recovery after 3 to 8 hours. Darker irides tend to dilate slower than lighter irides. Clinical efficacy and safety is supported by published literature. See Section 4.8 for additional information.</p><p><br /><strong>Paediatric population</strong><br />Systemic absorption of sufficient quantities of MYDFRIN may lead to systemic &alpha;- adrenergic effects, such as rise in blood pressure which may be accompanied by a reflex atropine-sensitive bradycardia. For information concerning posology, precautions,&nbsp;and warnings for pediatric subjects see Section 4.2 and 4.4, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong><br />MYDFRIN crosses the cornea and into the aqueous humor after topical ocular administration to rabbits. Tmax in aqueous humor was reported as 1 hour with a Cmax of 20.2 &mu;M after three drops of 2.5% dosing solution. Cmax dramatically increased after the removal of cornea&rsquo;s epithelium layer by17-fold, with a decrease in Tmax. Plasma concentrations in man after topical dosing with MYDFRIN 25 mg/ml eye drops, solution was&nbsp; pproximately 3 ng/mL, and approximately 10 ng/mL after topical ocular dosing with the MYDFRIN 100 mg/ml eye drops, solution.</p><p><br />After oral administration, absorption is complete but oral bioavailability is highly variable with reported value of 38% because of metabolism in the GI tract. However recently, that value has been challenged suggesting that bioavailability is considerable lower then was reported from radiolabel studies. The reported Tmax range in plasma after oral administration is 0.75 to 2 hours.</p><p><br /><strong>Distribution</strong><br />In rabbits, MYDFRIN distributes to the iris-ciliary body after topical ocular administration with a Tmax of 1 hour. Cornea and iris-cillary body exposure was greater than those found in the aqueous humor.</p><p><br />The volume of distribution (Vd) after IV administration has been reported in normal adult subjects as 340 &plusmn; 174 L with a reported Vd range of 184-543 L. Plasma protein binding of MYDFRIN* is 95%.</p><p><strong>Biotransformation</strong><br />MYDFRIN metabolism occurs in the corneal epithelium in the rabbit after topical ocular administration. Monoamine oxidase activity has also been found in iris-ciliary body and in retina and choroid.</p><p><br />Systemic metabolism in man involves deamination of MYDFRIN by monoamine oxidase which produces an aldehyde which is subsequently metabolized to m-hydroxmandelic acid by aldehyde dehydrogenase. Additional conversion of the acid by catechol-O-methyl transferase does occur. Conjugations of the parent drug or metabolite by sulfotransferases and glucuronyltransferases are also important metabolic pathways for MYDFRIN The metabolites, sulfate conjugate of MYDFRIN (47% of dose after PO administration), m- hydroxymandelic acid (30% of the dose after PO administration), glucuronide conjugate of MYDFRIN (12%); along with other minor metabolites have been identified in human urine. Conjugates of MYDFRIN are also major species in plasma after PO administration with plasma parent drug concentrations below the limit of quantitation. MYDFRIN after systemic dosing has demonstrated drug-drug interaction with known monoamine oxidase inhibitors.</p><p><br /><strong>Elimination</strong><br />In rabbit, the half-life for MYDFRIN in the aqueous humor was reported to be approximately 1 - 1.5 hours after topical ocular administration of MYDFRIN 100 mg/ml eye drops, solution.<br />After oral administration, MYDFRIN undergoes extensive pre-systemic metabolism in the GI tract after oral administration. After IV and PO administration, unchanged MYDFRIN in urine accounted for only 16% and 2.6% of the dose, respectively. Elimination half-life<br />after PO and IV administration averaged 2-3 hours. The systemic clearance for MYDFRIN after IV administration has been reported to be 2095 mL/min.</p><p><br /><strong>Linearity/non-linearity</strong><br />Linear pharmacokinetics after topical ocular administration of MYDFRIN 25 mg/ml and 100 mg/ml eye drops, solution is suggested from the systemic exposure (AUC) in man.</p><p><br /><strong>Pharmacokinetic/pharmacodynamic relationship(s)</strong><br />After topical ocular administration, a clockwise hysteresis was observed when effect (mydriasis) was plotted against aqueous humor concentrations in rabbit. Km and time plots indicated that Km increased after 90 min with the higher MYDFRIN 100 mg/ml eye drops, solution. This<br />observed tolerance has multiple possible mechanisms; but most likely results in a decrease in receptor activity.</p><p><br /><strong>Pharmacokinetics in Special Populations</strong><br />There are no reports of clinical pharmacokinetics in pediatrics, the elderly, or in hepatic or renal compromised patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard of MYDFRIN 25 mg/ml eye drops, solution for humans, when used as recommended, based on conventional studies of general toxicity, genotoxicity, carcinogenicity and toxicity to reproduction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Bisulfite<br />Boric Acid<br />Edetate Disodium (Dihydrate)<br />Sodium Hydroxide and/or Hydrochloric Acid<br />Purified Water<br />Benzalkonium Chloride</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Protect from light and excessive heat.<br />Do not use this medicine after the expiry date which is stated on the packaging.<br />Discard 4 weeks after first opening.<br />Keep this medicine out of the sight and reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 mL low density polyethylene bottles and plug with polypropylene closure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Alcon Research Limited,
Fort Worth,
Texas 76134,
USA
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>